Autres langues Tissue Repair Ltd

Actions

TRP

AU0000180887

Marché Fermé - Australian S.E. Autres places de cotation 06:53:18 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,23 ^AUD	0,00%		-4,17%	+4,55%

29/02	Tissue Repair Limited annonce un changement de secrétaire général	CI
28/02	Tissue Repair Ltd publie ses résultats pour le semestre clôturé le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Tissue Repair Limited Announces Change of Company Secretary	29/02
Tissue Repair Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Tissue Repair Secures Third US Patent for Glucoprime Compound	19/12
17,604,240 Options of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 18-NOV-2023.	18/11
13,684,488 Ordinary Shares of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 18-NOV-2023.	18/11
Tissue Repair Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Tissue Repair Limited Announces Company Secretary Changes	28/06/23
Tissue Repair Secures US FDA Clearance for Phase Three Leg Ulcer Trial	29/05/23
Tissue Repair Ltd Appoints Michael Silberberg as Director	02/05/23
Tissue Repair Ltd Announces Board Resignations	26/04/23
Tissue Repair Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	22/02/23
Tissue Repair to Test TR-987 Drug in 2023	29/09/22
Tissue Repair Ltd Announces Change of Company Secretary	28/09/22
Tissue Repair Limited Announces That It Has Received Responses to the Matters Raised in the Type C Meeting That the Company Submitted to the FDA on June 29, 2022	28/09/22
Tissue Repair Secures Second US Patent for Use of Active Ingredient in Skin Conditions	05/09/22
Tissue Repair Limited to Enter a Phase 3 Program in Venous Leg Ulcers	05/09/22
BridgeBio Pharma Affiliate Phoenix Tissue Repair Announces Positive Results from Phase 2 Trial of PTR-01, a Protein Replacement Therapy for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)	23/05/22
3,770,440 Ordinary Shares of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 30-APR-2022.	30/04/22
Australian Shares Fall Amid Global Selloff as Russia Continues Assault on Ukraine	04/03/22
Tissue Repair Secures US Patent Approval for Wound Drug; Shares Sink 8%	04/03/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Tissue Repair Ltd

Actions

TRP

AU0000180887

Autres langues

Filtres